TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.
Start Monitoring Your Investments

Immunomedics, Inc. (NASDAQ:IMMU) Investor Investigation Announced

  • If you purchased shares of Immunomedics, Inc. (NASDAQ:IMMU) and currently hold any of those NASDAQ:IMMU shares, you have certain options and you should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this investigation, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Investigation Overview

Company
Immunomedics, Inc.
Security
NASDAQ: IMMU

Summary

An investigation on behalf of current long-term investors in shares of Immunomedics, Inc. (NASDAQ:IMMU) was announced over potential breaches of fiduciary duties by certain officers and directors at Immunomedics.

The investigation by a law firm concerns whether certain Immunomedics directors breached their fiduciary duties and caused damage to the company and its shareholders.

Morris Plains, NJ based Immunomedics, Inc. is a clinical-stage biopharmaceutical company. Immunomedics, Inc. reported that Total Revenue declined from $3.23 million for the 12 months period that ended on June 30, 2016 to $3.09 million for the 12 months period that ended on June 30, 2017 and that its Net Loss increased over those time periods from $59.04 million to $153.21 million.

Shares of Immunomedics, Inc. (NASDAQ:IMMU) closed on December 18, 2017 at $12.69 per share.

Start Monitoring Your Investments